Related references
Note: Only part of the references are listed.Comparable Efficacy and Better Safety of Double β-Lactam Combination Therapy versus β-Lactam plus Aminoglycoside in Gram-Negative Bacteria in Randomized, Controlled Trials
Yuanyuan Jiao et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
First Penicillin-Binding Protein Occupancy Patterns of β-Lactams and β-Lactamase Inhibitors in Klebsiella pneumoniae
Dhruvitkumar S. Sutaria et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Optimization of Synergistic Combination Regimens against Carbapenem- and Aminoglycoside-Resistant Clinical Pseudomonas aeruginosa Isolates via Mechanism-Based Pharmacokinetic/Pharmacodynamic Modeling
Rajbharan Yadav et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
CARD 2017: expansion and model-centric curation of the comprehensive antibiotic resistance database
Baofeng Jia et al.
NUCLEIC ACIDS RESEARCH (2017)
Aminoglycosides against carbapenem-resistant Enterobacteriaceae in the critically ill: the pitfalls of aminoglycoside susceptibility
Alexandre P. Zavascki et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2017)
Predictive compound accumulation rules yield a broad - spectrum antibiotic
Michelle F. Richter et al.
NATURE (2017)
Aminoglycoside Concentrations Required for Synergy with Carbapenems against Pseudomonas aeruginosa Determined via Mechanistic Studies and Modeling
Rajbharan Yadav et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Klebsiella pneumoniae Major Porins OmpK35 and OmpK36 Allow More Efficient Diffusion of β-Lactams than Their Escherichia coli Homologs OmpF and OmpC
Etsuko Sugawara et al.
JOURNAL OF BACTERIOLOGY (2016)
Toward the Rational Design of Carbapenem Uptake in Pseudomonas aeruginosa
Vincent M. Isabella et al.
CHEMISTRY & BIOLOGY (2015)
Natural Variants of the KPC-2 Carbapenemase have Evolved Increased Catalytic Efficiency for Ceftazidime Hydrolysis at the Cost of Enzyme Stability
Shrenik C. Mehta et al.
PLOS PATHOGENS (2015)
Rapid detection of porins by matrix-assisted laser desorption/ionization-time of flight mass spectrometry
Yan-Yan Hu et al.
FRONTIERS IN MICROBIOLOGY (2015)
Pharmacokinetics of imipenem in critically ill patients during empirical treatment of nosocomial pneumonia: A comparison of 0.5-h and 3-h infusions
Michal Lips et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2014)
Pharmacokinetics of meropenem and piperacillin in critically ill patients with indwelling surgical drains
Syamhanin Adnan et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2013)
Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases
L. Silvia Munoz-Price et al.
LANCET INFECTIOUS DISEASES (2013)
The Efflux Inhibitor Phenylalanine-Arginine Beta-Naphthylamide (PAβN) Permeabilizes the Outer Membrane of Gram-Negative Bacteria
Ryan P. Lamers et al.
PLOS ONE (2013)
Modeling and Simulation Workbench for NONMEM: Tutorial on Pirana, PsN, and Xpose
R. J. Keizer et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2013)
Mechanistic insights from comparing intrinsic clearance values between human liver microsomes and hepatocytes to guide drug design
Li Di et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2012)
Identification of acquired antimicrobial resistance genes
Ea Zankari et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
OmpA Is the Principal Nonspecific Slow Porin of Acinetobacter baumannii
Etsuko Sugawara et al.
JOURNAL OF BACTERIOLOGY (2012)
Klebsiella pneumoniae Outer Membrane Porins OmpK35 and OmpK36 Play Roles in both Antimicrobial Resistance and Virulence
Yu-Kuo Tsai et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
The Effects of Hypoalbuminaemia on Optimizing Antibacterial Dosing in Critically Ill Patients
Marta Ulldemolins et al.
CLINICAL PHARMACOKINETICS (2011)
Relevance of Pharmacokinetic and Pharmacodynamic Modeling to Clinical Care of Critically Ill Patients
Jurgen B. Bulitta et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2011)
Characterization of Cellular Uptake of Perfluorooctanoate via Organic Anion-Transporting Polypeptide 1A2, Organic Anion Transporter 4, and Urate Transporter 1 for Their Potential Roles in Mediating Human Renal Reabsorption of Perfluorocarboxylates
Ching-Hui Yang et al.
TOXICOLOGICAL SCIENCES (2010)
Outer membrane permeability and antibiotic resistance
Anne H. Delcour
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2009)
Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution
Jason A. Roberts et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
β-Lactam Resistance Response Triggered by Inactivation of a Nonessential Penicillin-Binding Protein
Bartolome Moya et al.
PLOS PATHOGENS (2009)
Application of basic pharmacokinetic concepts to analysis of microdialysis data - Illustration with imipenem muscle distribution
Claire Dahyot et al.
CLINICAL PHARMACOKINETICS (2008)
Rate-limiting steps in hepatic drug clearance: Comparison of hepatocellular uptake and metabolism with microsomal metabolism of saquinavir, nelfinavir, and ritonavir
Alison J. Parker et al.
DRUG METABOLISM AND DISPOSITION (2008)
Analyzing real-time PCR data by the comparative C-T method
Thomas D. Schmittgen et al.
NATURE PROTOCOLS (2008)
The porin and the permeating antibiotic: a selective diffusion barrier in Gram-negative bacteria
Jean-Marie Pages et al.
NATURE REVIEWS MICROBIOLOGY (2008)
Penicillin-binding proteins and beta-lactam resistance
Andre Zapun et al.
FEMS MICROBIOLOGY REVIEWS (2008)
A survey of population analysis methods and software for complex pharmacokinetic and pharmacodynamic models with examples
Robert J. Bauer et al.
AAPS JOURNAL (2007)
Population pharmacokinetics and pharmacodynamics of continuous versus short-term infusion of imipenem-cilastatin in critically ill patients in a randomized, controlled trial
Samir G. Sakka et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Computational systems biology in drug discovery and development: methods and applications
Wayne Materi et al.
DRUG DISCOVERY TODAY (2007)
Cellular uptake and efflux of azithromycin, erythromycin, clarithromycin, telithromycin, and cethromycin
M Bosnar et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
A statistical model for identifying proteins by tandem mass spectrometry
AI Nesvizhskii et al.
ANALYTICAL CHEMISTRY (2003)
Molecular basis of bacterial outer membrane permeability revisited
H Nikaido
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2003)
Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search
A Keller et al.
ANALYTICAL CHEMISTRY (2002)
Method for estimation of low outer membrane permeability to β-lactam antibiotics
B Lakaye et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Pharmacokinetics and pharmacodynamics of meropenem in critically ill patients
R Kitzes-Cohen et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2002)
Novel carbapenem-hydrolyzing β-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae
H Yigit et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Multidrug-resistant bacteria: overcoming antibiotic permeability barriers of Gram-negative bacteria
PB Savage
ANNALS OF MEDICINE (2001)
Intermittent and continuous ceftazidime infusion for critically ill trauma patients
SD Hanes et al.
AMERICAN JOURNAL OF SURGERY (2000)
Contributions of the AmpC β-lactamase and the AcrAB multidrug efflux system in intrinsic resistance of Escherichia coli K-12 to β-lactams
A Mazzariol et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Share Paper
